Epilepsy phenotypes of Renu syndrome: Novel insights from a European multicentre retrospective cohort study
Por:
Mastrangelo, M, Tolve, M, Valenzuela, I, Lentini, G, Cinnante, EMC, Masotto, B, D'Arrigo, S, Ajmone, PF, Rosenblum, J, Milani, D, Rodriguez-Palmero, A, Ciaccio, C, Jansen, AC and Pisani, F
Publicada:
1 feb 2026
Ahead of Print:
1 ene 2026
Resumen:
Background: Epilepsy is a prominent feature in about 60% of patients with ReNU syndrome Patients and methods: Data including demographics, gene variants, seizure semiology and evolution, EEG patterns, neurodevelopmental features, MRI characteristics and response to antiseizure medications were retrospectively collected in a cohort of patients with ReNU syndrome referred to 6 European tertiary centres. Results: The cohort included 10 patients (7 males and 3 females). The mean age at epilepsy onset was 2.8 +/- 2.1 years. No specific epilepsy syndromes were recognized. Focal impaired consciousness with observable manifestations (with onset before 12 months in 3 cases) were the predominant seizure type across all age ranges. The frequency of this seizure type peaked between the ages of 6 and 11 years. Generalized seizures were less common and mainly occurred under the age of 6 with a similar frequency of atypical absences and tonic/tonic clonic seizures. Interictal and ictal epileptiform EEG were more frequently detected after 3 years of age and were mainly focal (with predominant involvement of the fronto-parietal regions). No structural epileptogenic lesions were detected on MRI. Seizure freedom was achieved with antiseizure medications in 5 patients at a mean age of 7.2 +/- 25.2. Valproate was judged the most effective medication by referring neurologists followed by levetiracetam, clobazam, lamotrigine and phenytoin. No relevant genotype-phenotype correlations were observed. Conclusions: The phenotype of the seizure disorders observed in this cohort was dominated by focal impaired consciousness seizures with observable manifestations and a relatively favourable course of epilepsy.
Filiaciones:
Mastrangelo, M:
Sapienza Univ Rome, Woman Child Hlth & Urol Sci Dept, Via Sabelli 108, I-00185 Rome, Italy
Azienda Osped Univ Policlin Umberto, Dept Neurosci Mental Hlth, Unit Child Neurol & Psychiat, Rome, Italy
Tolve, M:
Azienda Osped Univ Policlin Umberto, Unit Clin Pathol, Rome, Italy
Valenzuela, I:
Vall dHebron Hosp, Clin & Mol Genet Area, Barcelona, Spain
Vall dHebron Res Inst VHIR, Med Genet Grp, Barcelona, Spain
Lentini, G:
Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy
Cinnante, EMC:
Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy
Masotto, B:
Hosp Univ Germans Trias I Pujol, Clin Genet Dept, Lab Clin Metropolitana Nord, Barcelona, Spain
Vall dHebron Hosp, Vall dHebron Res Inst VHIR, Clin & Mol Genet Area, Barcelona, Spain
D'Arrigo, S:
Fdn IRCCS Ist Neurol Carlo Besta, Dept Pediat Neurosci, Milan, Italy
Ajmone, PF:
Fdn IRCCS Ca Grande Osped Maggiore Policlin, Child & Adolescent Neuropsychiat Serv UONPIA, Milan, Italy
Rosenblum, J:
Univ Antwerp, Antwerp Univ Hosp, Ctr Med Genet Antwerp, Edegem, Belgium
Univ Antwerp, Translat Neurosci, Antwerp, Belgium
Milani, D:
Univ Antwerp, Translat Neurosci, Antwerp, Belgium
Fdn IRCCS Ca Granda Osped Maggiore, Milan, Italy
:
Fdn IRCCS Ca Granda Osped Maggiore, Milan, Italy
Univ Autonoma Barcelona, Hosp Univ Germans Trias I Pujol, Dept Pediat, Paediat Neurol Unit, Barcelona, Spain
Jansen, AC:
Univ Antwerp, Antwerp Univ Hosp, Ctr Med Genet Antwerp, Edegem, Belgium
Pisani, F:
Azienda Osped Univ Policlin Umberto, Dept Neurosci Mental Hlth, Unit Child Neurol & Psychiat, Rome, Italy
Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy
Green Submitted, hybrid
|